Patent · US Expired

Protein kinase C inhibitor

US6117861A · kind A · utility

6Cited by
3References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 7, 1999
Grant dateSep 12, 2000
Priority date
Expiry dateDec 7, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides novel bis-indolylmaleimide macrocycle derivatives of the formula: ##STR1## and solvates thereof. The invention further provides the preparation, pharmaceutical formulations and the methods of use for inhibiting Protein Kinase C in mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.